Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-11

Clinical Trial Update: Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on combining a gonadotropin-releasing hormone agonist with human chorionic gonadotropin trigger for normal responders in GnRH-anta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: In-vitro Fertilization | Phase 3 | Status: UNKNOWN